New Merck KGgA viral vector CDMO plant opens in California
Merck KGgA and subsidiary MilliporeSigma have completed work on their second Carlsbad, California-based facility.
Stay updated with breaking news from Upstream Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merck KGgA and subsidiary MilliporeSigma have completed work on their second Carlsbad, California-based facility.
LEXEO Therapeutics, a clinical-stage gene therapy company, is partnering with CDMO, Fujifilm Diosynth Biotechnologies (FDB), to support the development and manufacturing of its AAV-mediated gene therapies.
Avid Bioservices, Inc. is expanding its CDMO service offering into the cell and gene therapy market: constructing a purpose-built 53,000 sq. ft. viral vector development and CGMP manufacturing facility in Costa Mesa, CA.
Measuring total LNG supply chain methane emissions is imprecise, but there is an even bigger data gap when it comes to coal. Without accurate measurement, the benefits of coal-to-LNG switching risk being under-appreciated. [Gas in Transition, Volume 1, Issue 6]
PTC Therapeutics is celebrating the opening of a new gene therapy manufacturing facility in Hopewell, N.J.